HK Stock Market Move | Cssc Offshore & Marine Engineering (00317) rose more than 5% in early trading. The company will release its performance tomorrow, with first quarter earnings exceeding market expectations.
China Shipbuilding Industry Corporation (00317) rose more than 5% in the morning session, up 5.64% as of press time, trading at HKD 16.3 with a turnover of HKD 52.58 million.
Cssc Offshore & Marine Engineering (00317) rose more than 5% in the morning session, as of press time, up 5.64% to HK$16.3, with a turnover of HK$52.5856 million.
On the news front, Cssc Offshore & Marine Engineering will release its first quarter performance announcement on April 29. The company had previously announced a profit forecast, expecting a net profit attributable to shareholders of the company of RMB 360 million to RMB 430 million in the first quarter, an increase of 95.16% to 133.11% year-on-year. Shenwan Hongyuan Group released a research report stating that the performance exceeded expectations, mainly due to the accelerated delivery pace of civilian ships at its controlling shipyard Huangpu Wenchong and affiliated shipyard Guangzhou Shipyard International, leading to an acceleration in profit release.
The bank pointed out that in terms of industry catalysts, new ship prices have stabilized and are expected to enter a unilateral upward trend. The oil shipping industry entered a super cycle in early 2026, with prosperity accelerating towards shipbuilding. New orders are expected to accelerate, with the rise in new oil tanker prices leading to an overall increase in the new ship price index, and long-term performance of ship companies is expected to improve.
Related Articles

J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.






